A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease. (17th October 2022)
- Record Type:
- Journal Article
- Title:
- A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease. (17th October 2022)
- Main Title:
- A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease
- Authors:
- He, Kaiyin
Guo, Li-Liangzi
Tang, Huijun
Peng, Xiaojuan
Li, Juan
Feng, Shufen
Bie, Caiqun
Chen, Weiwei
Li, Yuting
Wang, Min
Tang, Shaohui - Abstract:
- Abstract : INTRODUCTION: We aimed to assess the effects of 2 isoenergetic intervention diets (a freshwater fish-based diet [F group] or freshwater fish-based and red meat-based diets alternately [F/M group]) on liver steatosis and their relationship with intestinal flora in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: In this open-label, 84-day randomized controlled trial, 34 NAFLD patients with hepatic steatosis ≥10% were randomly assigned to the F group or F/M group in a 1:1 ratio using a computer-generated random number allocation by a researcher not involved in the study. Liver fat content and gut microbiota and its metabolites were measured. RESULTS: At the end of intervention, the absolute reduction of hepatic steatosis was significantly greater in the F group than in the F/M group (−4.89% vs −1.83%, P = 0.032). Of the 16 secondary clinical outcomes, the improvement in 7 in the F group was greater compared with the F/M group, including alanine aminotransferase and gamma-glutamyl transferase. Furthermore, dietary freshwater fish and red meat consumption alternately did not exacerbate NAFLD. Moreover, changes in the enrichment of Faecalibacterium, short-chain fatty acids, and unconjugated bile acids and the depletion of Prevotella 9 and conjugated bile acids in the F group were significantly greater compared with the F/M group. DISCUSSION: Higher intake of freshwater fish may be beneficial to NAFLD by regulating gut microbiota and its metabolites,Abstract : INTRODUCTION: We aimed to assess the effects of 2 isoenergetic intervention diets (a freshwater fish-based diet [F group] or freshwater fish-based and red meat-based diets alternately [F/M group]) on liver steatosis and their relationship with intestinal flora in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: In this open-label, 84-day randomized controlled trial, 34 NAFLD patients with hepatic steatosis ≥10% were randomly assigned to the F group or F/M group in a 1:1 ratio using a computer-generated random number allocation by a researcher not involved in the study. Liver fat content and gut microbiota and its metabolites were measured. RESULTS: At the end of intervention, the absolute reduction of hepatic steatosis was significantly greater in the F group than in the F/M group (−4.89% vs −1.83%, P = 0.032). Of the 16 secondary clinical outcomes, the improvement in 7 in the F group was greater compared with the F/M group, including alanine aminotransferase and gamma-glutamyl transferase. Furthermore, dietary freshwater fish and red meat consumption alternately did not exacerbate NAFLD. Moreover, changes in the enrichment of Faecalibacterium, short-chain fatty acids, and unconjugated bile acids and the depletion of Prevotella 9 and conjugated bile acids in the F group were significantly greater compared with the F/M group. DISCUSSION: Higher intake of freshwater fish may be beneficial to NAFLD by regulating gut microbiota and its metabolites, whereas intake of a similar total of animal protein and fat from the alternating freshwater fish and red meat may not be harmful for NAFLD in the dietary management of patients with NAFLD. Abstract : … (more)
- Is Part Of:
- American journal of gastroenterology. Volume 117:Number 10(2022)
- Journal:
- American journal of gastroenterology
- Issue:
- Volume 117:Number 10(2022)
- Issue Display:
- Volume 117, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 117
- Issue:
- 10
- Issue Sort Value:
- 2022-0117-0010-0000
- Page Start:
- 1621
- Page End:
- 1631
- Publication Date:
- 2022-10-17
- Subjects:
- Stomach -- Diseases -- Periodicals
Intestines -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Gastrointestinal Diseases -- Periodicals
Electronic journals
Periodicals
616.33 - Journal URLs:
- http://www.mdconsult.com/public/search?search_type=journal&j_sort=pub_date&j_date_range=1995-current&j_issn=0002-9270 ↗
http://www.amjgastro.com/ ↗
http://www.nature.com/ajg/archive/index.html ↗
http://www.sciencedirect.com/science/journal/00029270 ↗
http://www.nature.com/ ↗
http://www3.interscience.wiley.com/journal/117955841/home ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0002-9270;screen=info;ECOIP ↗ - DOI:
- 10.14309/ajg.0000000000001885 ↗
- Languages:
- English
- ISSNs:
- 0002-9270
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0824.650000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24288.xml